MO

Unknown

872 clinical trials

Find Trials

Clinical Trials (872)

Showing 20 of 872 trialsScroll for more

Drug Wastage : Observational Study in the Operating Rooms of France

Completed

Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

Active Not Recruiting
NCT07091630Phase 31 site

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Recruiting
NCT07096193Phase 13 sites

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Recruiting
NCT06980116Phase 11 site

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Recruiting
NCT06619990Phase 11 site

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Recruiting
NCT06806852Phase 11 site

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Active Not Recruiting
NCT07633288Phase 21 site

A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Recruiting
NCT07367074Not Applicable1 site

Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC)

Completed
NCT06902519Phase 11 site

Study of GS-0151 in Participants With Rheumatoid Arthritis

Recruiting
NCT06361537Phase 31 site

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Recruiting
NCT07363590Phase 11 site

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

Recruiting
NCT07472517Phase 31 site

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

Recruiting
NCT05249426Phase 11 site

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

Active Not Recruiting
NCT07012395Phase 25 sites

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Recruiting
NCT02908906Phase 11 site

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Active Not Recruiting
NCT04577833Phase 11 site

A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer

Active Not Recruiting
NCT02592317Phase 11 site

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Active Not Recruiting
NCT06613360Phase 11 site

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Recruiting
NCT02354014Phase 21 site

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Recruiting